Cargando…
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol
OBJECTIVE: There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to inve...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647577/ https://www.ncbi.nlm.nih.gov/pubmed/35047691 http://dx.doi.org/10.1136/bmjos-2019-100055 |
_version_ | 1784610633082208256 |
---|---|
author | Righi, Elda Scudeller, Luigia Chiamenti, Margherita Abdelraouf, Kamilia Lodise, Thomas Carrara, Elena Savoldi, Alessia Menghin, Dario Pellizzari, Gloria Ellis, Sally Franceschi, Francois Piddock, Laura Rebuffi, Chiara Sanguinetti, Maurizio Tacconelli, Evelina |
author_facet | Righi, Elda Scudeller, Luigia Chiamenti, Margherita Abdelraouf, Kamilia Lodise, Thomas Carrara, Elena Savoldi, Alessia Menghin, Dario Pellizzari, Gloria Ellis, Sally Franceschi, Francois Piddock, Laura Rebuffi, Chiara Sanguinetti, Maurizio Tacconelli, Evelina |
author_sort | Righi, Elda |
collection | PubMed |
description | OBJECTIVE: There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to investigate in vivo effects of antibiotic combination on mortality and disease burden for infections due to CR Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacteriaceae and provide an unbiased overview of existing knowledge. The results of the study can help prioritising future research on the most promising therapies against CR bacteria. METHODS AND ANALYSIS: This protocol was formulated using the Systematic Review Protocol for Animal Intervention Studies (SYRCLE) Checklist. Publications will be collected from PubMed, Scopus, Embase and Web of Science. Quality checklists adapted by Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies and SYRCLE’s risk of bias tool will be used. If the meta-analysis seems feasible, the ES and the 95% CI will be analysed. The heterogeneity between studies will be assessed by I(2) test. Subgroup meta-analysis will be performed when possible to assess the impact of the studies on efficacy of the treatments. Funnel plotting will be used to evaluate the risk of publication bias. DISSEMINATION: This systematic review and meta-analysis is part of a wider research collaboration project, the COmbination tHErapy to treat sepsis due to carbapenem-Resistant bacteria in adult and paediatric population: EvideNCE and common practice (COHERENCE) study that includes also the analyses of in vitro and human studies. Data will be presented at international conferences and the results will be published in peer-reviewed journals. PROSPERO REGISTRATION NUMBER: CRD42019128104(available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128104). |
format | Online Article Text |
id | pubmed-8647577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-86475772022-01-18 In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol Righi, Elda Scudeller, Luigia Chiamenti, Margherita Abdelraouf, Kamilia Lodise, Thomas Carrara, Elena Savoldi, Alessia Menghin, Dario Pellizzari, Gloria Ellis, Sally Franceschi, Francois Piddock, Laura Rebuffi, Chiara Sanguinetti, Maurizio Tacconelli, Evelina BMJ Open Sci Protocol OBJECTIVE: There is poor evidence to determine the superiority of combination regimens versus monotherapy against infections due to carbapenem-resistant (CR) Gram-negative bacteria. In vivo models can simulate the pathophysiology of infections in humans and assess antibiotic efficacy. We aim to investigate in vivo effects of antibiotic combination on mortality and disease burden for infections due to CR Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacteriaceae and provide an unbiased overview of existing knowledge. The results of the study can help prioritising future research on the most promising therapies against CR bacteria. METHODS AND ANALYSIS: This protocol was formulated using the Systematic Review Protocol for Animal Intervention Studies (SYRCLE) Checklist. Publications will be collected from PubMed, Scopus, Embase and Web of Science. Quality checklists adapted by Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies and SYRCLE’s risk of bias tool will be used. If the meta-analysis seems feasible, the ES and the 95% CI will be analysed. The heterogeneity between studies will be assessed by I(2) test. Subgroup meta-analysis will be performed when possible to assess the impact of the studies on efficacy of the treatments. Funnel plotting will be used to evaluate the risk of publication bias. DISSEMINATION: This systematic review and meta-analysis is part of a wider research collaboration project, the COmbination tHErapy to treat sepsis due to carbapenem-Resistant bacteria in adult and paediatric population: EvideNCE and common practice (COHERENCE) study that includes also the analyses of in vitro and human studies. Data will be presented at international conferences and the results will be published in peer-reviewed journals. PROSPERO REGISTRATION NUMBER: CRD42019128104(available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019128104). BMJ Publishing Group 2020-07-21 /pmc/articles/PMC8647577/ /pubmed/35047691 http://dx.doi.org/10.1136/bmjos-2019-100055 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Protocol Righi, Elda Scudeller, Luigia Chiamenti, Margherita Abdelraouf, Kamilia Lodise, Thomas Carrara, Elena Savoldi, Alessia Menghin, Dario Pellizzari, Gloria Ellis, Sally Franceschi, Francois Piddock, Laura Rebuffi, Chiara Sanguinetti, Maurizio Tacconelli, Evelina In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol |
title | In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol |
title_full | In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol |
title_fullStr | In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol |
title_full_unstemmed | In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol |
title_short | In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol |
title_sort | in vivo studies on antibiotic combination for the treatment of carbapenem-resistant gram-negative bacteria: a systematic review and meta-analysis protocol |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647577/ https://www.ncbi.nlm.nih.gov/pubmed/35047691 http://dx.doi.org/10.1136/bmjos-2019-100055 |
work_keys_str_mv | AT righielda invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT scudellerluigia invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT chiamentimargherita invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT abdelraoufkamilia invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT lodisethomas invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT carraraelena invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT savoldialessia invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT menghindario invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT pellizzarigloria invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT ellissally invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT franceschifrancois invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT piddocklaura invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT rebuffichiara invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT sanguinettimaurizio invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol AT tacconellievelina invivostudiesonantibioticcombinationforthetreatmentofcarbapenemresistantgramnegativebacteriaasystematicreviewandmetaanalysisprotocol |